WHO GMP in 2026: Inspection Readiness and Compliance Expectations

Professional standing inside a regulated pharmaceutical cleanroom, illustrating contamination control in drug manufacturing, GMP quality management system oversight, facility design and equipment qualification, and regulatory inspection readiness.

This article explains how global pharmaceutical GMP standards are applied during inspections, why operational gaps persist despite formal compliance, and how quality systems, contamination control, and risk-based execution shape regulatory inspection readiness across manufacturing operations.